Genomics meets transgenics in search of the elusive Cryptosporidium drug target

Trends in Parasitology

Volumn 20, Issue 8, 2004, Pages 355-358

  Striepen, Boris ^a   Kissinger, Jessica C ^a  

^a UNIVERSITY OF GEORGIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEAT SHOCK PROTEIN 70; INOSINATE DEHYDROGENASE; MYCOPHENOLIC ACID; RIBAVIRIN;

ANTIGEN EXPRESSION; APICOPLAST; COMPARATIVE GENOMIC HYBRIDIZATION; CRYPTOSPORIDIUM PARVUM; DATA BASE; DNA LIBRARY; DRUG TARGETING; ENZYME INHIBITION; GENE EXPRESSION; GENE IDENTIFICATION; GENE MAPPING; GENE SEQUENCE; MOLECULAR CLONING; NONHUMAN; POLYMERASE CHAIN REACTION; PROTEIN ANALYSIS; PROTEIN EXPRESSION; REVIEW; SACCHAROMYCES CEREVISIAE; TOXOPLASMA GONDII;

CRYPTOSPORIDIUM; CRYPTOSPORIDIUM PARVUM; PROTOZOA; SACCHAROMYCES; SACCHAROMYCES CEREVISIAE; TOXOPLASMA GONDII;

EID: 3142775639     PISSN: 14714922     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pt.2004.06.003     Document Type: Short Survey

References (28)

1. MacKenzie W.R., et al. Massive outbreak of waterborne Cryptosporidium infection in Milwaukee, Wisconsin: recurrence of illness and risk of secondary transmission. Clin. Infect. Dis. 21:1995;57-62
2. Fayer R., et al. The general biology of Cryptosporidium. Fayer R. Cryptosporidium and Cryptosporidiosis. 1997;1-41 CRC Press Inc
3. Mead J.R. Cryptosporidiosis and the challenges of chemotherapy. Drug Resist. Updat. 5:2002;47-57
4. Hunter P.R., Nichols G. Epidemiology and clinical features of Cryptosporidium infection in immunocompromised patients. Clin. Microbiol. Rev. 15:2002;145-154
5. Brophy V.H., et al. Identification of Cryptosporidium parvum dihydrofolate reductase inhibitors by complementation in Saccharomyces cerevisiae. Antimicrob. Agents Chemother. 44:2000;1019-1028
6. Roos D.S., et al. Molecular tools for genetic dissection of the protozoan parasite Toxoplasma gondii. Methods Cell Biol. 45:1994;27-63
7. Roos D.S., et al. Tagging genes and trapping promoters in Toxoplasma gondii by insertional mutagenesis. Methods. 13:1997;112-122
8. Boothroyd J.C., et al. Toxoplasma gondii as a paradigm for the use of genetics in the study of protozoan parasites. Methods Mol. Genet. 6:1994;1-29
9. Meissner M., et al. Role of Toxoplasma gondii myosin A in powering parasite gliding and host cell invasion. Science. 298:2002;837-840
10. Striepen B., et al. Genetic complementation in apicomplexan parasites. Proc. Natl. Acad. Sci. U. S. A. 99:2002;6304-6309
11. Woods K.M., Upton S.J. Efficacy of select antivirals against Cryptosporidium parvum in vitro. FEMS Microbiol. Lett. 168:1998;59-63
12. Widmer G., et al. Genomics and genetics of Cryptosporidium parvum: the key to understanding cryptosporidiosis. Microbes Infect. 4:2002;1081-1090
13. Abrahamsen M.S., et al. Complete genome sequence of the Apicomplexan, Cryptosporidium parvum. Science. 304:2004;441-445
14. Puiu D., et al. CryptoDB: The Cryptosporidium genome resource. Nucleic Acids Res. 32:2004;D329-D331
15. Tzipori S., Griffiths J.K. Natural history and biology of Cryptosporidium parvum. Adv. Parasitol. 40:1998;5-36
16. Zhu G., et al. Cryptosporidium parvum appears to lack a plastid genome. Microbiology. 146:2000;315-321
17. Fichera M.E., Roos D.S. A plastid organelle as a drug target in apicomplexan parasites. Nature. 390:1997;407-409
18. Riordan C.E., et al. Cryptosporidium parvum Cpn60 targets a relict organelle. Curr. Genet. 44:2003;138-147
19. Slapeta J., Keithly J.S. Cryptosporidium parvum mitochondrial-type HSP70 targets homologous and heterologous mitochondria. Eukaryot., Cell. 3:2004;483-494
20. LaGier M.J., et al. Mitochondrial-type iron-sulfur cluster biosynthesis genes (IscS and IscU) in the apicomplexan Cryptosporidium parvum. Microbiology. 149:2003;3519-3530
21. Striepen B., et al. Gene transfer in the evolution of parasite nucleotide biosynthesis. Proc. Natl. Acad. Sci. U. S. A. 101:2004;3154-3159
22. Mushegian A.R., Koonin E.V. A minimal gene set for cellular life derived by comparison of complete bacterial genomes. Proc. Natl. Acad. Sci. U. S. A. 93:1996;10268-10273
23. O'Connor R.M., et al. Expression of CpGp40/15 in Toxoplasma gondii: a surrogate system for the expression of Cryptosporidium glycoproteins. Infect. Immun. 71:2003;6027-6034
24. Radke J.R., et al. Identification of a sporozoite-specific member of the Toxoplasma SAG superfamily via genetic complementation. Mol. Microbiol. 52:2004;93-105
25. McFadden D.C., et al. Use of Toxoplasma gondii expressing beta-galactosidase for colorimetric assessment of drug activity in vitro. Antimicrob. Agents Chemother. 41:1997;1849-1853
26. Gubbels M.J., et al. High-throughput growth assay for Toxoplasma gondii using yellow fluorescent protein. Antimicrob. Agents Chemother. 47:2003;309-316
27. Fox B.A., Bzik D.J. De novo pyrimidine biosynthesis is required for virulence of Toxoplasma gondii. Nature. 415:2002;926-929
28. Pfefferkorn E.R., Pfefferkorn L.C. Toxoplasma gondii: isolation and preliminary characterization of temperature-sensitive mutants. Exp. Parasitol. 39:1976;365-376